Common Foot Injuries and Their Characteristics

Lisfranc injury is a type of foot injury that occurs when one or more metatarsal bones are displaced from the tarsus. This injury is usually caused by excessive kinetic energy being placed on the midfoot, such as in a traffic collision. There are two types of Lisfranc injuries: direct and indirect. A direct injury occurs when the foot is crushed by a heavy object, while an indirect injury occurs when there is sudden rotational force on a plantar flexed foot.

March fracture is another common foot injury that is caused by repetitive stress on the distal third of one of the metatarsal bones. This injury is often seen in soldiers and hikers who walk long distances. The onset of foot pain is gradual and progressive, and there is often trauma associated with it.

Hallux Rigidus is a degenerative arthritis that causes bone spurs at the metatarsophalangeal joint of the big toe, making it painful and stiff. Jones fracture is a fracture in the meta-diaphyseal junction of the fifth metatarsal of the foot. Proximal fifth metatarsal avulsion fracture is caused by forcible inversion of the foot in plantar flexion, such as when stepping on a kerb or climbing steps.

These different foot injuries have their own unique characteristics and causes. these injuries can help individuals take preventative measures to avoid them and seek appropriate treatment if necessary.

Differentiating Arthritis Types: Avascular Necrosis, Gout, Osteoarthritis, Pseudogout, and Septic Arthritis

Arthritis is a common condition that affects the joints, causing pain, stiffness, and inflammation. However, there are different types of arthritis, each with its own causes, symptoms, and treatments. Here are some key points to differentiate between avascular necrosis, gout, osteoarthritis, pseudogout, and septic arthritis:

Avascular necrosis is a condition where the bone tissue dies due to a lack of blood supply. It can be caused by corticosteroid use, malignancy, or trauma. Femoral head collapse is a classic radiographic change in avascular necrosis.

Gout is a type of crystal arthritis that usually affects peripheral joints, such as the big toe, ankle, or knee. It is caused by the buildup of uric acid crystals in the joint, leading to sudden attacks of pain, redness, and swelling.

Osteoarthritis is a degenerative joint disease that occurs when the cartilage that cushions the joints wears down over time. It is more common in older adults and can affect any joint, but femoral head collapse does not occur in osteoarthritis.

Pseudogout is another type of crystal arthritis that usually affects peripheral joints. It is caused by the buildup of calcium pyrophosphate crystals in the joint, leading to similar symptoms as gout.

Septic arthritis is a bacterial infection of the joint that can cause severe pain, swelling, and fever. It is a medical emergency and requires prompt treatment with antibiotics. While septic arthritis should always be considered in a monoarthritis, it is less likely in cases where there are classic radiographic changes of avascular necrosis, risk factors, and a normal CRP without history of fever.

The patient in this scenario has systemic lupus erythematosus (SLE) with mild symptoms, primarily affecting the joints and skin. The first-line treatment for this type of SLE is hydroxychloroquine, which can induce remission and reduce recurrence. However, patients on this medication must be monitored for drug-induced retinopathy. Methotrexate may be used in more severe cases with active joint synovitis. Sun avoidance is important to prevent flares, but it is not enough to treat the patient’s current symptoms. Infliximab is not typically used to treat SLE, and rituximab is reserved for last-line therapy. Azathioprine is commonly used as a steroid-sparing agent in SLE, but hydroxychloroquine is more appropriate for this patient’s current presentation. The main adverse effect of azathioprine is bone marrow suppression, which can be life-threatening in some patients.

Differential Diagnosis for a Young Man with Purpura and Haematuria

The patient in question presents with a purpuric rash on the back, buttocks, and extensor surfaces of the lower limbs, as well as haematuria. The following is a differential diagnosis of possible conditions that could be causing these symptoms.

Henoch–Schönlein purpura (HSP)
The clinical presentation is entirely typical of HSP, a vasculitic process that results in a purpuric rash and haematuria. It should be noted that platelet numbers are usually normal or raised in HSP, so thrombocytopaenia is not expected.

Haemophilia A
This condition is not likely as it results in joint and muscle bleeding, which is not present in this case. Additionally, haemophilia would not cause haematuria.

Idiopathic thrombocytopaenic purpura (ITP)
While purpura is a symptom of ITP, a reduced platelet count is typically present. Without a discussion of platelet levels, it is difficult to justify a diagnosis of ITP. Additionally, ITP would not result in haematuria.

Leukaemia
If acute leukaemia were causing the symptoms, thrombocytopaenia might be expected. However, the clinical presentation is more compatible with HSP, and thrombocytopaenia alone would not result in haematuria.

Thalassaemia trait
There is no indication in the history to suggest this condition, and it would not result in purpura. Thalassaemia trait is typically asymptomatic.

In conclusion, the patient’s symptoms are most consistent with HSP, a vasculitic process that results in a purpuric rash and haematuria.

Treatment Options for Acute Gout Flare in a Patient with Peptic Ulcer Disease

When managing an acute gout flare in a patient with a history of peptic ulcer disease, it is important to consider the potential risks and benefits of different treatment options. Colchicine and non-steroidal anti-inflammatory drugs (NSAIDs) are both effective first-line treatments, but NSAIDs should be used with caution in patients with a history of peptic ulcer disease. If NSAIDs are used, proton-pump cover should be provided for gastric protection. Allopurinol should not be started until after the acute attack has been resolved, and paracetamol may be used as an adjunct for pain relief but would not treat the underlying cause of pain. Prednisolone may be used in patients unable to tolerate NSAIDs or colchicine, but there is no contraindication to a trial of oral colchicine in this patient. Overall, the choice of treatment should be individualized based on the patient’s medical history and preferences.

Treatment Options for Rheumatoid Disease: A Comparison of Biological Therapies and DMARDs

Rheumatoid disease can be a debilitating condition that requires careful management. When standard disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief, biological therapies may be prescribed. Infliximab, adalimumab, and etanercept are some of the contemporary biological therapies available. Infliximab, in particular, is often co-prescribed with methotrexate, although it may cause a reversible lupus-like syndrome and tuberculosis reactivation.

Combining gold, leflunomide, and methotrexate is unlikely to help patients who have already failed DMARD therapy. Azathioprine may be considered in severe cases, but biological therapy is the preferred treatment when intensive DMARD therapy fails. The combination of gold and penicillamine is a viable option for patients who meet the criteria for biological therapy, according to National Institute for Health and Care Excellence (NICE) guidelines. DMARD monotherapy, such as leflunomide, is only recommended when dual therapy is contraindicated.

In summary, the choice of treatment for rheumatoid disease depends on the severity of the condition and the patient’s response to previous therapies. Biological therapies may offer relief for patients who have failed DMARD therapy, but careful monitoring for potential side effects is necessary.

Migratory tenosynovitis can be caused by disseminated gonococcal infection in younger adults, particularly women. It is important to test for C6-C9 complement deficiency. Rheumatoid arthritis can also cause tenosynovitis, but it is not migratory and is usually found in the interphalangeal, metacarpophalangeal, and wrist joints. Scleroderma can cause tenosynovitis, but it is not migratory either. Fluoroquinolone toxicity may increase the risk of tendinopathy and tendon rupture, but it does not cause migratory tenosynovitis. Reactive arthritis can cause tendinitis, but it is more prevalent in men and is not migratory. It is a rheumatoid factor-seronegative arthritis that can be linked with HLA-B27.

Polymyalgia Rheumatica/Temporal arthritis: Symptoms and Importance of Diagnosis

Polymyalgia rheumatica/temporal arthritis is a condition that may present with predominantly polymyalgia symptoms such as proximal muscle pain, stiffness, or arthritis symptoms such as headaches, scalp tenderness, and jaw claudication. It is also common for the condition to have systemic involvement, including fever, malaise, and weight loss. One of the key indicators of this condition is a very high ESR.

The main reason for diagnosing and treating polymyalgia rheumatica/temporal arthritis is to prevent blindness. This condition can cause inflammation in the blood vessels that supply the eyes, leading to vision loss. Therefore, early diagnosis and treatment are crucial to prevent this complication.

Importance of Joint Aspiration in Identifying the Cause of Acute Monoarthropathy

When a patient presents with acute monoarthropathy, it is important to identify the cause of their symptoms. The most important investigation in this case is joint aspiration. This procedure involves taking a sample of fluid from the affected joint and examining it under a microscope to identify any infective organisms. This is crucial in cases where septic arthritis is suspected, as appropriate therapy can be guided based on the results. On the other hand, if the cause is gout, joint aspiration can reveal the presence of crystals in the fluid. X-rays are of no value in septic arthritis as they only become abnormal following joint destruction. Therefore, joint aspiration is the most important investigation in identifying the cause of acute monoarthropathy.

Treatment Options for Severe Rheumatoid Arthritis

Severe rheumatoid arthritis can be a challenging condition to manage, especially when conventional disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief. In such cases, biological therapies may be recommended. Here are some treatment options for severe rheumatoid arthritis:

Enrol in Biological Therapy Programme
Patients with highly active disease despite trying three previous agents for a therapeutic treatment duration may be candidates for biological treatments. TNF-alpha inhibitors and anti-CD20 are examples of biological treatments that are routinely used in the UK.

Maintain on Steroids and Add a Bisphosphonate
Short-term treatment with glucocorticoids may be offered to manage flares in people with recent-onset or established disease. However, long-term treatment with glucocorticoids should only be continued when the long-term complications of glucocorticoid therapy have been fully discussed and all other treatment options have been offered.

Commence Leflunomide
Severe disease that has not responded to intensive therapy with a combination of conventional DMARDs should be treated with biological agents. Leflunomide is one of the DMARDs that can be used in combination therapy.

Use Methotrexate/Leflunomide Combination
Patients who have not responded to intensive DMARD therapy may be prescribed a biological agent, as per NICE guidelines. Methotrexate and leflunomide are two DMARDs that can be used in combination therapy.

Avoid Commencing Penicillamine
DMARD monotherapy is only recommended if combination DMARD therapy is not appropriate. Patients without contraindications to combination therapy should not be prescribed penicillamine.